Clinical Trial Update: PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PEX010-assisted therapy for stimulant use disorder is not yet recruiting. The sponsor listed is Filament Health Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stimulant Use Disorder

Drugs mentioned

• PEX010 (PEX010)

Snippet

Sponsor: Filament Health Corp. | Conditions: Stimulant Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING